title: Pharmacoeconomic guidelines: where do we go from here?
authors.forename: M
authors.initials: M
authors.lastname: Berger
mesh_terms: D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017408:Guidelines as Topic; D006302:Health Services Research / Q000191:economics / Q000379:methods*